Graves' disease and hyperprolactinemia in a patient with Noonan syndrome neurofibromatosis type 1;Maladie de Graves-Basedow et hyperprolactinéme chez une femme atteinte du syndrome de Noonan/neurofibromatose de type 1

Annales d'Endocrinologie

Volumn 65, Issue 2, 2004, Pages 121-124

  Bolko, P ^a   Wasko, R ^a   Waligorska J ^a   Narozna, J ^a   Sowinski J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Graves' disease; Hyperprolactinemia; Neurofibromatosis type 1; Noonan syndrome; Osteoporosis

Indexed keywords

RADIOISOTOPE;

ADULT; ARTICLE; BONE DEFECT; BONE DENSITY; CASE REPORT; FEMALE; GRAVES DISEASE; HORMONE BLOOD LEVEL; HUMAN; HYPERPROLACTINEMIA; HYPERTHYROIDISM; IODINE 131 UPTAKE TEST; NEUROFIBROMATOSIS; NOONAN SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; SHORT STATURE; SUBCUTANEOUS NODULE; THYROID GLAND; THYROID SCINTISCANNING; ULTRASOUND;

EID: 3042631700     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4266(04)95659-4     Document Type: Article

References (22)

1. Amoroso A, Garzia P, Vadacca M, Galluzzo S, Del Porto F, Mitterhofer AP, Afeltra A. The unsual association of three autoimmune disease in patients with Noonan syndrome. J Adolesc Health 2003; 32 (1): 94-7.
2. Andler W, Roosen K, Kohns U, Stolecke H. Endokrine Storungen bei Kindern mit Neurofibromatose von Reckinghausen. Monatsschr Kinderheikd 1979; 127: 135-8.
3. Baralle D, Mattocks C, Kalidas K et al.: Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndroma (NFNS). Am J Med. Gent 2003; 119A (1): 1-8.
4. Brasfield RD, Das Gupta TK. Von Recklinghausens disease: Clinicopathological study. Ann Surg 1987; 175: 86-92.
5. Buehning L, Curry CJ. Neurofibromatosis-Noonan syndrom. Pediatr. Dermatol 1995; 12: 267-71.
6. Colley A, Donnai D, Evans DG. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet 1996; 42 (2): 59-64.
7. Chaglassian JH, Riseborough EJ, Hall JE. Neurofibromatous scoliosis: Natural history and results of treatment in thirty-seven cases. Surgery 1976; 580: 695-702.
8. Jacquemin C., Bosley Th M, Liu D, Svedberg H, Buhaliqa A. Reassessment of sphenoid dysplasia associated with neurofibromatosis type 1. Am J Neuroradiol 2002; 23: 644-8.
9. Disimone RE, Brman AT, Schwentker EP. The orthopedic manifestation of neurofibromatosis. Clin Orthop 1988; 230: 277-82.
10. Illes T, Halmai V, de Jonge T, Dubousset J. Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 2000; 12: 823-7.
11. Kim HW, Weinstein SL. The managment of scoliosis in neurofibromatosis. Spine 1997; 22: 2770-6.
12. Laue L, Comite F, Hench K, Loriauz DL, Cuttler GB, Pesscovits OH. Precocious puberty associated with neurofibromatosis and optic gliomas. Am J Disabled Child 1985; 139: 1097-100.
13. Pulst SM, Graham JM Ir, Fian P, Barker D, Pribyl T, Korenberg JR. The achondroplasia gene is not linked to the locus for neurofibromatosis 1 on chromosome. Hum Genet 1990; 85: 12-4.
14. Pulst SM, Pribyl T, Barker DF, Riccardi VM, Ren M, Yaahi H, Korenberg JR. Molecular analysis of a patient with neurofibromatosis 1 and achondropasia. Am J Med Genet 1997; 40: 84-7.
15. Rasmussen S.A., Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol 2000; 151: 33-40.
16. Riccardi VM, ed, Neurofibromatosis: Phenotype, natural histology, and pathogenesis, Chapters 11 and 12. Skeletal, hematologic and endocrine systems. Baltimore: John Hopkons University Press, 1992: 142-94.
17. Sakane N, Shirakata S, Jin MB, Tori T, Yoshida T. Von Recklinhausen. Disease with hyperthyroidism. Intern Med 1997; 36 (12): 938.
18. Schorry EK, Lovell AM, Milatovich A, Saal HM. Ullrich-Turner syndrome and neurofibromarosis-1. Am J Med Genet 1996; 66: 423-5.
19. Shuper A, Mukamel M, Mimouni M, Steinherz R. Noonan's syndrome and neurofibromatosis. Arch Dis Child 1987; 62: 196-8.
20. Soliman AT, Rajab A, el Zalabany M, alSalmi I, Fattah MA. Defective growth hormone (GH) secretion and short- term treatment in Noonan syndrome. Indian J Pediatr 1998; 65: 741-9.
21. Bernauer TA, Miranowski GW, Coldemeyer KS. Neurofibromatosis type I. Part II. Non - head and neck findings. J Am Acad Dermatol 2001; 44: 1027-9.
22. Vassilopoulou-Sellin R, Klein MJ, Slopis JK. Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions. Pediatr Neurol 2000; 22: 355-8.